Through a public notice, the National Testing Agency (NTA) has announced the reopening of the registration window for the National Eligibility-cum-Entrance Test for (Undergraduate) courses- NEET UG 2024. As per the notice, the NTA, “received various representations from stakeholders with a request to re-open the registration window of NEET (UG)- 2024”. For more information, click […]
Kozhikode: In a distressing incident reported in Kozhikode, a retired doctor fell victim to a marriage scam orchestrated by a gang of four who duped him of Rs 6 lakh, a phone and a laptop. The doctor, who had advertised his interest in marriage through a newspaper, was targeted by individuals identified as Irshana, […]
UK: A coronary sinus reducer (CSR) implant showed a symptom alleviation benefit for people with stable coronary artery disease and refractory angina, according to a small placebo-controlled ORBITA-COSMIC trial. “The number of self-reported daily angina episodes shifted downward significantly among people randomized to the Neovasc Reducer intervention instead of a sham procedure (OR 1.40),” the […]
Lucknow: The Department of Sports Medicine at state-run King George’s Medical University (KGMU) has introduced a minimally invasive surgical technique to address a rare and debilitating hip condition known as hip synovial chondromatosis. Affecting only one in a lakh individuals, this condition causes severe pain and mobility limitations. This innovative approach, a first for the […]
China: A 24-week, phase 3 trial has shed light on the safety and efficacy of bexagliflozin versus dapagliflozin as an adjunct to metformin in Chinese patients with type 2 diabetes mellitus (T2D). Bexagliflozin and dapagliflozin are sodium-glucose cotransporter-2 (SGLT2) inhibitors. According to the study, bexagliflozin, when used in Chinese patients on metformin, showed nearly identical […]
A recent phase 2 clinical trial found positive outcomes in patients with pemphigus a rare and potentially life-threatening autoimmune disease. The study focused on the use of rilzabrutinib which is an oral, reversible, covalent Bruton tyrosine kinase (BTK) inhibitor to manage pemphigus. The results of this clinical trial were published in the recent issue of […]
Inflammatory bowel disease (IBD) is a chronic inflammatory condition of the gastrointestinal tract, affecting millions worldwide. Bowel resection is a common surgical intervention in IBD patients, with significant implications for quality of life. While vitamin D has been studied for its anti-inflammatory and immune-modulating properties, its association with bowel resection risk in IBD remains unclear. […]
Researchers at Tel Aviv University (TAU) and the Leviev Cardiothoracic and Vascular Center at the Sheba Medical Center have found a mechanism which is responsible for increasing the risk of developing cancer among patients with heart disease: those small extracellular bubbles, or vesicles (sEVs), that are secreted from the sick heart to heal itself are […]
A recent study that could revolutionize the treatment approach for severe gastroesophageal reflux disease (GERD) unveiled compelling evidence that support the efficacy of Potassium-competitive acid blockers (P-CAB) over the traditional Proton Pump Inhibitors (PPI) in treating grade C/D esophagitis. This severe manifestation of GERD requires active treatment and diligent follow-up due to its significant impact […]
South Korea: Findings from two Korean cohort studies revealed that simply lowering cholesterol intake may not be sufficient to prevent chronic kidney disease (CKD). The study was published online in Nutrition, Metabolism and Cardiovascular Diseases. The researchers showed that although cholesterol intake was associated with increased serum cholesterol levels, it was not associated with CKD […]